Q&A with Oncimmune CEO, Dr Adam M Hill

In this interview, CEO Adam Hill takes Vox through Oncimmune's #ONC in line FY’22 results, exciting growth trajectory & positive outlook. Alongside detailing its path to profitability and near-term funding options.

Watch the video interview HERE